Physician profile
Robert Monaco
NPI 1033296504
$3,366.06
in general payments reported to CMS, 2019-2025
16 companies · $664 in 2025
The $664 reported for 2025 was more than what 86% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $300 · 2021: $47.14 · 2022: $148 · 2023: $193 · 2024: $1,821 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,571 · Travel and Lodging: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,570.61 |
| Travel and Lodging | $1,106.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,220.70 | 2022-2024 | Iovera, Zilretta |
| Bioventus LLC | $674.26 | 2019-2025 | Durolane, L360 Thigh System, Xcell |
| Samsung Medison Co., Ltd. | $300.00 | 2020 | |
| Sonex Health, INC. | $258.75 | 2025 | Sx-One Microknife |
| Ge Healthcare | $246.02 | 2024 | |
| Ferring Pharmaceuticals INC. | $165.62 | 2019-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $158.69 | 2019-2025 | Orthovisc, Monovisc |
| Samsung Hme America, INC. | $130.00 | 2019-2023 | |
| Averitas Pharma INC. | $59.65 | 2024-2025 | Qutenza |
| Avanos Medical | $32.50 | 2023 | Generator |
| Vertex Pharmaceuticals Incorporated | $32.24 | 2025 | |
| Hydrocision, INC. | $23.24 | 2024 | Tenjet |
| Abbott Laboratories | $18.85 | 2024 | Eterna |
| Sanofi-Aventis U.S. LLC | $16.84 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.57 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.13 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Monaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.